chartexchange

Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London

GlobeNewswire Inc. | Oct 29, 2026 7:00 AM EDT

BURLINGTON, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in the 2026 Jefferies Global Healthcare Conference in London.

Read original article